July 28, 2016 11:53 PM ET


Company Overview of Anesta Corp.

Company Overview

Anesta Corp. is engaged in the development of pharmaceutical products for oral transmucosal drug administration. The company's product, Actiq®, approved by the U.S. Food and Drug Administration, was designed for breakthrough cancer pain. As of October 10, 2000, Anesta Corp. operates as a subsidiary of Cephalon Inc.

4745 Wiley Post Way

Salt Lake City, UT 84116

United States

88 Employees



Key Executives for Anesta Corp.

Vice President - Finance and Vice President - Administration
Age: 51
Chairman of the Board and Treasurer
Age: 77
Secretary and Director
Age: 76
Senior Vice President
Age: 60
Vice President - European Operations
Age: 56
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Anesta Corp., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.